Table
4: Univariate
analysis of clinical variables factors affecting development of DN.
Clinical variables |
ba |
Crude OR (95 % CI) |
P value |
HbA1c (1st visit) |
-0.07 |
0.92
(0.85,1.00) |
0.069 |
HbA1c (2nd visit) |
-0.07 |
0.92
(0.85,1.00) |
0.066 |
HbA1c (3rd visit) |
-0.08 |
0.92
(0.85,0.99) |
0.046 |
HbA1c (4th visit) |
-0.09 |
0.90
(0.83,0.98) |
0.024 |
FPG (1st visit) |
-0.00 |
0.99
(0.94,1.04) |
0.792 |
FPG (2nd visit) |
-0.05 |
0.94
(0.89,0.99) |
0.031 |
FPG (3rd visit) |
-0.01 |
0.99
(0.93,1.04) |
0.702 |
FPG (4th visit) |
-0.05 |
0.94
(0.90,0.98) |
0.008 |
PPG (1st visit) |
0.03 |
1.03
(0.98,1.08) |
0.226 |
PPG (2nd visit) |
0.00 |
0.99
(0.95,1.04) |
0.851 |
PPG (3rd visit) |
0.01 |
1.01
(0.96,1.06) |
0.674 |
PPG (4th visit) |
0.02 |
1.02
(0.97,1.08) |
0.367 |
TG (1st visit) |
0.28 |
1.32
(1.01,1.74) |
0.039 |
TG (2nd visit) |
0.22 |
1.25
(0.95,1.64) |
0.107 |
TG (3rd visit) |
0.39 |
1.47
(1.10,1.96) |
0.008 |
TG (4th visit) |
0.66 |
1.94
(1.38,2.72) |
< 0.001 |
TCH (1st visit) |
0.11 |
1.11
(0.92,1.34) |
0.239 |
TCH (2nd visit) |
-0.03 |
0.96
(0.82,1.14) |
0.695 |
TCH (3rd visit) |
0.15 |
1.16
(0.97,1.40) |
0.100 |
TCH (4th visit) |
0.14 |
1.15
(0.97,1.37) |
0.106 |
HDL (1st visit) |
-0.02 |
0.97
(0.67,1.41) |
0.892 |
HDL (2nd visit) |
-0.29 |
0.74
(0.54,1.02) |
0.072 |
HDL (3rd visit) |
0.11 |
1.01
(0.92,1.10) |
0.811 |
HDL (4th visit) |
0.01 |
0.98
(0.97,1.00) |
0.141 |
LDL (1st visit) |
0.08 |
1.09
(0.89,1.32) |
0.390 |
LDL (2nd visit) |
-0.01 |
0.98
(0.83,1.17) |
0.886 |
LDL (3rd visit) |
0.00 |
0.97
(0.95,1.04) |
0.906 |
LDL (4th visit) |
0.01 |
1.01
(0.99,1.03) |
0.147 |
SBP (1st visit) |
0.02 |
1.02(1.00,1.03) |
0.00l |
SBP (2nd visit) |
0.00 |
1.00
(0.99,1.02) |
0.108 |
SBP (3rd visit) |
0.00 |
1.01
(0.99,1.02) |
0.181 |
SBP (4th visit) |
0.01 |
1.00
(0.99,1.02) |
0.140 |
DBP (1st visit) |
0.00 |
1.00
(0.98,1.02) |
0.588 |
DBP (2nd visit) |
0.00 |
0.99
(0.97,1.01) |
0.388 |
D
BP (3rd visit) |
0.00 |
0.99
(0.97,1.01) |
0.679 |
DBP (4th visit) |
0.00 |
1.00
(0.98,1.01) |
0.936 |
Crcl
(1st visit) |
-0.10 |
0.90
(0.88,0.91) |
<0.001 |
Crcl
(2nd visit) |
-0.08 |
0.91
(0.90,0.93) |
<0.001 |
Crcl
(3rd visit) |
-0.10 |
0.90
(0.88,0.91) |
<0.001 |
Crcl
(4th visit) |
0.00 |
0.99
(0.99,1.00) |
0.472 |
OR: Odds
Ratio; CI: Confidence Interval; (HbA1c):
Hemoglobin A1c; (FPG): Fasting Plasma Glucose; (PPG): Postprandial
Plasma Glucose; (LDL): Low Density Lipoproteins; (HDL): High Density Lipoproteins; (TCH): Total Cholesterol; (TG): Triglyceride;
(SBP): Systolic Blood Pressure; (DBP): Diastolic Blood Pressure and (CrCl): Creatinine Clearance.
aSimple logistic regression ( outcome as
nephropathy complications).